Review article
PCSK9 inhibitors in the current management of atherosclerosis
Los inhibidores de la PCSK9 en el manejo clínico actualizado de la aterosclerosis
Thomas F. Whayne Jr
Autor para correspondencia
twhayn0@uky.edu
Correspondence to: Gill Heart Institute, 326 Wethington Building, 900 South Limestone Street, Lexington, KY 40536-0200, USA. Tel.: +1 859 218 5332; fax: +1 859 257 6060.
Correspondence to: Gill Heart Institute, 326 Wethington Building, 900 South Limestone Street, Lexington, KY 40536-0200, USA. Tel.: +1 859 218 5332; fax: +1 859 257 6060.
División de Medicina Cardiovascular, Instituto Gill del Corazón, Facultad de Medicina de la Universidad de Kentucky, Lexington, KY, USA
Leído
8201
Vecesse ha leído el artículo
1337
Total PDF
6864
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 141 | 9 | 150 |
| 2025 11 | 398 | 29 | 427 |
| 2025 10 | 99 | 14 | 113 |
| 2025 9 | 41 | 13 | 54 |
| 2025 8 | 63 | 15 | 78 |
| 2025 7 | 53 | 5 | 58 |
| 2025 6 | 34 | 8 | 42 |
| 2025 5 | 31 | 2 | 33 |
| 2025 4 | 30 | 3 | 33 |
| 2025 3 | 56 | 6 | 62 |
| 2025 2 | 75 | 3 | 78 |
| 2025 1 | 71 | 3 | 74 |
| 2024 12 | 67 | 6 | 73 |
| 2024 11 | 43 | 3 | 46 |
| 2024 10 | 59 | 8 | 67 |
| 2024 9 | 54 | 6 | 60 |
| 2024 8 | 45 | 11 | 56 |
| 2024 7 | 40 | 10 | 50 |
| 2024 6 | 28 | 2 | 30 |
| 2024 5 | 38 | 2 | 40 |
| 2024 4 | 42 | 2 | 44 |
| 2024 3 | 77 | 10 | 87 |
| 2024 2 | 91 | 14 | 105 |
| 2024 1 | 86 | 5 | 91 |
| 2023 12 | 84 | 9 | 93 |
| 2023 11 | 76 | 8 | 84 |
| 2023 10 | 77 | 12 | 89 |
| 2023 9 | 66 | 6 | 72 |
| 2023 8 | 43 | 5 | 48 |
| 2023 7 | 32 | 3 | 35 |
| 2023 6 | 50 | 3 | 53 |
| 2023 5 | 60 | 4 | 64 |
| 2023 4 | 64 | 3 | 67 |
| 2023 3 | 65 | 5 | 70 |
| 2023 2 | 51 | 2 | 53 |
| 2022 1 | 56 | 7 | 63 |
| 2022 12 | 46 | 5 | 51 |
| 2022 11 | 65 | 14 | 79 |
| 2022 10 | 45 | 7 | 52 |
| 2022 9 | 58 | 12 | 70 |
| 2022 8 | 72 | 10 | 82 |
| 2022 7 | 37 | 10 | 47 |
| 2022 6 | 32 | 4 | 36 |
| 2022 5 | 31 | 6 | 37 |
| 2022 4 | 36 | 13 | 49 |
| 2022 3 | 43 | 10 | 53 |
| 2022 2 | 65 | 7 | 72 |
| 2021 1 | 90 | 11 | 101 |
| 2021 12 | 41 | 10 | 51 |
| 2021 11 | 84 | 20 | 104 |
| 2021 10 | 181 | 19 | 200 |
| 2021 9 | 73 | 10 | 83 |
| 2021 8 | 76 | 9 | 85 |
| 2021 7 | 35 | 7 | 42 |
| 2021 6 | 61 | 19 | 80 |
| 2021 5 | 83 | 12 | 95 |
| 2021 4 | 174 | 39 | 213 |
| 2021 3 | 171 | 25 | 196 |
| 2021 2 | 83 | 24 | 107 |
| 2020 1 | 81 | 12 | 93 |
| 2020 12 | 93 | 23 | 116 |
| 2020 11 | 105 | 13 | 118 |
| 2020 10 | 66 | 4 | 70 |
| 2020 9 | 86 | 9 | 95 |
| 2020 8 | 135 | 18 | 153 |
| 2020 7 | 205 | 15 | 220 |
| 2020 6 | 116 | 13 | 129 |
| 2020 5 | 152 | 19 | 171 |
| 2020 4 | 134 | 23 | 157 |
| 2020 3 | 127 | 8 | 135 |
| 2020 2 | 114 | 35 | 149 |
| 2020 1 | 91 | 22 | 113 |
| 2019 12 | 73 | 13 | 86 |
| 2019 11 | 36 | 4 | 40 |
| 2019 10 | 23 | 10 | 33 |
| 2019 9 | 46 | 11 | 57 |
| 2019 8 | 14 | 4 | 18 |
| 2019 7 | 20 | 12 | 32 |
| 2019 6 | 46 | 11 | 57 |
| 2019 5 | 140 | 35 | 175 |
| 2019 4 | 43 | 24 | 67 |
| 2019 3 | 13 | 33 | 46 |
| 2019 2 | 15 | 7 | 22 |
| 2019 1 | 8 | 4 | 12 |
| 2018 12 | 14 | 7 | 21 |
| 2018 11 | 15 | 3 | 18 |
| 2018 10 | 18 | 18 | 36 |
| 2018 9 | 31 | 7 | 38 |
| 2018 8 | 32 | 7 | 39 |
| 2018 7 | 12 | 1 | 13 |
| 2018 6 | 16 | 6 | 22 |
| 2018 5 | 16 | 14 | 30 |
| 2018 4 | 14 | 6 | 20 |
| 2018 3 | 14 | 1 | 15 |
| 2018 2 | 10 | 3 | 13 |
| 2018 1 | 12 | 2 | 14 |
| 2017 12 | 9 | 5 | 14 |
| 2017 11 | 16 | 7 | 23 |
| 2017 10 | 19 | 14 | 33 |
| 2017 9 | 38 | 24 | 62 |
| 2017 8 | 15 | 14 | 29 |
| 2017 7 | 28 | 16 | 44 |
| 2017 6 | 41 | 24 | 65 |
| 2017 5 | 71 | 26 | 97 |
| 2017 4 | 63 | 24 | 87 |
| 2017 3 | 122 | 57 | 179 |
| 2017 2 | 53 | 23 | 76 |
| 2016 1 | 35 | 87 | 122 |
Mostrar todo